EyePoint Plc (EYPT)
15.99
-0.11
(-0.68%)
USD |
NASDAQ |
Dec 12, 16:00
15.98
0.00 (0.00%)
After-Hours: 20:00
EyePoint Cash from Investing (Quarterly): 55.38M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 91.34M |
| Agios Pharmaceuticals, Inc. | 95.56M |
| Viking Therapeutics, Inc. | 160.02M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -59.35M |
| Cash from Financing (Quarterly) | 7.403M |
| Free Cash Flow | -213.59M |
| Free Cash Flow Per Share (Quarterly) | -0.8573 |
| Free Cash Flow to Equity (Quarterly) | -61.60M |
| Free Cash Flow to Firm (Quarterly) | -60.15M |
| Free Cash Flow Yield | -19.47% |